Alpha to Omicron (Variants of Concern): Mutation Journey, Vaccines, and Therapy
- 1 March 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 36 (2), 83-100
- https://doi.org/10.1089/vim.2022.0122
Abstract
Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) initially emerged in December 2019 and has subsequently expanded globally, leading to the ongoing pandemic. The extensive spread of various SARS-CoV-2 variants possesses a serious public health threat. An extensive literature search along with deep analysis was performed to describe and evaluate the characteristics of SARS-CoV-2 variants of concern in relation to the effectiveness of the current vaccines and therapeutics. The obtained results showed that several significant mutations have evolved during the COVID-19 pandemic. The developed variants and their various structural mutations can compromise the effectiveness of several vaccines, escape the neutralizing antibodies, and limit the efficiency of available therapeutics. Furthermore, deep analysis of the available data enables the prediction of the future impact of virus mutations on the ongoing pandemic along with the selection of appropriate vaccines and therapeutics.Keywords
This publication has 145 references indexed in Scilit:
- The Hydrophobic Domain of Infectious Bronchitis Virus E Protein Alters the Host Secretory Pathway and Is Important for Release of Infectious VirusJournal of Virology, 2011
- The SARS Coronavirus E Protein Interacts with PALS1 and Alters Tight Junction Formation and Epithelial MorphogenesisMolecular Biology of the Cell, 2010
- Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in miceVaccine, 2009
- DARPins: A new generation of protein therapeuticsDrug Discovery Today, 2008
- The SARS-CoV nucleocapsid protein: A protein with multifarious activitiesInfection, Genetics and Evolution, 2008
- Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and DJournal of Virology, 2007
- Role of the Coronavirus E Viroporin Protein Transmembrane Domain in Virus AssemblyJournal of Virology, 2007
- Adjuvant effects of saponins on animal immune responsesJournal of Zhejiang University-SCIENCE B, 2007
- The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus worldProceedings of the National Academy of Sciences of the United States of America, 2004
- Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genesVirology, 1987